How the US Food and Drug Administration fares during President-elect Donald Trump’s second term will depend, in part, on industry’s support for the agency and its staff, says Commissioner Robert Califf.
Industry Support Key To US FDA’s Prospects Under Trump – Califf
The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."
